Woo Tsung-Ung W, Walsh John P, Benes Francine M
Program in Structural and Molecular Neuroscience, McLean Hospital, Belmont, and Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Arch Gen Psychiatry. 2004 Jul;61(7):649-57. doi: 10.1001/archpsyc.61.7.649.
Disturbances of gamma-aminobutyric acid interneurons in the cerebral cortex contribute to the pathophysiology of schizophrenia and bipolar disorder. The activity of these neurons is, in turn, modulated by glutamatergic inputs furnished by pyramidal neurons.
To test the hypothesis that glutamatergic inputs onto gamma-aminobutyric acid interneurons via the N-methyl-d-aspartate (NMDA) receptor are altered in the anterior cingulate cortex in schizophrenia and bipolar disorder.
A double in situ hybridization technique was used to simultaneously label the messenger RNA (mRNA) for the NMDA NR(2A) subunit with (35)sulfur and the mRNA for the 67-kDa isoform of the gamma-aminobutyric acid synthesizing enzyme glutamic acid decarboxylase (GAD(67)) with digoxigenin.
Postmortem human brain studies.
We studied 17 subjects with schizophrenia, 17 subjects with bipolar disorder, and 17 normal control subjects.
The density of all GAD(67) mRNA-containing neurons was decreased by 53% and 28%, in layers 2 and 5, respectively, in subjects with schizophrenia, whereas in subjects with bipolar disorder there was a 35% reduction in layer 2 only. For GAD(67) mRNA-containing neurons that co-expressed NR(2A)mRNA, their numerical density was decreased by 73% and 52%, in layers 2 and 5, respectively, in subjects with schizophrenia and by 60% in layer 2 in those with bipolar disorder. In the schizophrenia group, the density of the GAD(67)mRNA-containing neurons that did not co-express NR(2A)mRNA was also decreased by 42% in layer 2. In both disease groups, the expression level of NR(2A)mRNA in GAD(67) mRNA-containing cells was unaltered.
The density of gamma-aminobutyric acid interneurons that express the NMDA NR(2A)subunit appears to be decreased in schizophrenia and bipolar disorder. Future studies will address whether subpopulations of these neurons may be differentially affected in the 2 conditions.
大脑皮质中γ-氨基丁酸中间神经元的功能紊乱与精神分裂症和双相情感障碍的病理生理学有关。而这些神经元的活动又受到锥体细胞提供的谷氨酸能输入的调节。
验证精神分裂症和双相情感障碍患者前扣带回皮质中,通过N-甲基-D-天冬氨酸(NMDA)受体作用于γ-氨基丁酸中间神经元的谷氨酸能输入发生改变这一假说。
采用双重原位杂交技术,用(35)硫同时标记NMDA NR(2A)亚基的信使核糖核酸(mRNA),用地高辛标记γ-氨基丁酸合成酶谷氨酸脱羧酶(GAD(67))67-kDa亚型的mRNA。
尸体人脑研究。
研究17例精神分裂症患者、17例双相情感障碍患者和17名正常对照者。
精神分裂症患者第2层和第5层中,所有含GAD(67)mRNA的神经元密度分别降低了53%和28%,而双相情感障碍患者仅第2层降低了35%。对于共表达NR(2A)mRNA的含GAD(67)mRNA的神经元,其数量密度在精神分裂症患者的第2层和第5层分别降低了73%和52%,在双相情感障碍患者的第2层降低了60%。在精神分裂症组,第2层中不共表达NR(2A)mRNA的含GAD(67)mRNA的神经元密度也降低了42%。在两个疾病组中,含GAD(67)mRNA细胞中NR(2A)mRNA的表达水平均未改变。
在精神分裂症和双相情感障碍中,表达NMDA NR(2A)亚基的γ-氨基丁酸中间神经元密度似乎降低。未来的研究将探讨在这两种情况下,这些神经元的亚群是否可能受到不同的影响。